Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 88 filers reported holding Y-MABS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7 | -100.0% | 1,443 | 0.0% | 0.00% | – |
| Q3 2022 | $21,000 | -4.5% | 1,443 | 0.0% | 0.00% | – |
| Q2 2022 | $22,000 | +22.2% | 1,443 | 0.0% | 0.00% | – |
| Q1 2022 | $18,000 | -21.7% | 1,443 | 0.0% | 0.00% | – |
| Q4 2021 | $23,000 | -43.9% | 1,443 | 0.0% | 0.00% | – |
| Q3 2021 | $41,000 | -16.3% | 1,443 | 0.0% | 0.00% | – |
| Q2 2021 | $49,000 | +14.0% | 1,443 | 0.0% | 0.00% | – |
| Q1 2021 | $43,000 | -39.4% | 1,443 | 0.0% | 0.00% | – |
| Q4 2020 | $71,000 | +29.1% | 1,443 | 0.0% | 0.00% | – |
| Q3 2020 | $55,000 | -11.3% | 1,443 | 0.0% | 0.00% | – |
| Q2 2020 | $62,000 | +63.2% | 1,443 | 0.0% | 0.00% | – |
| Q1 2020 | $38,000 | -15.6% | 1,443 | 0.0% | 0.00% | – |
| Q4 2019 | $45,000 | +40.6% | 1,443 | +4.3% | 0.00% | – |
| Q2 2019 | $32,000 | – | 1,383 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $932,939 | 3.08% |
| Sofinnova Investments, Inc. | 2,194,278 | $10,708,077 | 0.64% |
| Artal Group S.A. | 400,000 | $1,952 | 0.11% |
| Polar Capital Holdings Plc | 1,991,929 | $9,720,614 | 0.08% |
| ASHFORD CAPITAL MANAGEMENT INC | 98,870 | $482,486 | 0.08% |
| Soleus Capital Management, L.P. | 87,182 | $425,448 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 99,160 | $484 | 0.06% |
| Cormorant Asset Management, LP | 150,000 | $732 | 0.05% |
| CORNERCAP INVESTMENT COUNSEL INC | 48,233 | $235,377 | 0.04% |
| XTX Topco Ltd | 38,574 | $188,241 | 0.04% |